Robert Goldfarb

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) are lower by 16 percent since the start of 2016 and lower by nearly 45 percent over the past year. The losses in Valeant Pharmaceuticals' stock has prompted a group of investors to sue an investment firm that saw more than $2 billion in...